AJP - Regulatory, Integrative and Comparative Physiology, Vol 256, Issue 3 616-R624, Copyright © 1989 by American Physiological Society

ARTICLES

Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens

S. Sirko, I. Bishai and F. Coceani
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

Conscious cats were used to study the local release of prostaglandin (PG) E2 and thromboxane (Tx) B2 (the stable TxA2 by-product) from the preoptic-anterior hypothalamus (AH-POA) and the tuberal-posterior hypothalamus (PH-Tu) using a modified "push-pull" perfusion procedure. In the absence of fever, PGE2 release was steady from the 2nd h of perfusion onward, its rate at either site ranging between 0.08 and 0.12 pg/min. Local treatment with probenecid (1 mM) increased PGE2 release about threefold. Compared with PGE2, basal release of TxB2 was greater (0.15-0.43 pg/min) and, occasionally, tended to fall with time. Both compounds were found in higher amounts (2- to 10-fold increase) after locally injecting endotoxin, and the effect was greater in AH-POA than PH-Tu. Conversely, intravenous endotoxin (bolus) or interleukin 1 (IL-1) (bolus plus infusion) at doses causing a sustained fever selectively stimulated the formation of PGE2, but the response itself did not differ between AH-POA and PH-Tu. In either region, the degree of enhancement in PGE2 release correlated with the magnitude of the fever. Intravenous indomethacin (2 mg/kg) reversed both the fever and PGE2 elevation. These findings support an intermediary role for PGE2 in the central action of pyrogens and the ensuing fever. Blood-borne pyrogens may act at multiple sites in brain, which are tentatively identified with the circumventricular organs.

This article has been cited by other articles:

				A. A. Steiner, A. Y. Rudaya, J. R. Robbins, A. S. Dragic, R. Langenbach, and A. A. Romanovsky Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1253 - R1257. [Abstract] [Full Text] [PDF]

				C. S. Wilcox and W. J. Welch Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II Am J Physiol Renal Physiol, March 1, 2003; 284(3): F525 - F531. [Abstract] [Full Text] [PDF]

				S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid Receptors: Structures, Properties, and Functions Physiol Rev, October 1, 1999; 79(4): 1193 - 1226. [Abstract] [Full Text] [PDF]

				T. A. Cudd Thromboxane A2 acts on the brain to mediate hemodynamic, adrenocorticotropin, and cortisol responses Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1353 - R1360. [Abstract] [Full Text] [PDF]

				C. S. Wilcox, H. Gao, J. G. Verbalis, and W. J. Welch Role of AVP in pressor responses during activation of central TxA2/PGH2 receptors Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1927 - H1932. [Abstract] [Full Text] [PDF]